Exploratory Trial of Navigational Bronchoscopy-Guided Cryoablation in Lung Cancer Treatment

NCT07301411 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2025-12-24

No results posted yet for this study

Summary

This clinical trial is an exploratory clinical trial with two cohorts:

Cohort 1: aiming to conduct a preliminary evaluation of the effectiveness and safety of the Navigational Bronchoscopy System and the Bronchoscope and Accessories (manufactured by Noah) in combination with the cryoablation therapy devices for the treatment of lung malignancies.

Cohort 2: aiming to conduct a preliminary evaluation of the effectiveness and safety of the Navigational Bronchoscopy System and the Bronchoscope and Accessories (manufactured by Puli Ark) in combination with the cryoablation therapy devices for the treatment of lung malignancies.

The overall objective of this study is to conduct a preliminary evaluation of the effectiveness and safety of navigational bronchoscopy - guided cryoablation therapy of the lungs through the above two cohorts.

Conditions

  • Lung Malignancies

Interventions

DEVICE

Cryoablation Therapy

Navigational Bronchoscopy System and Bronchoscope and Accessories in Combination with Cryoablation Therapy Device.

Sponsors & Collaborators

  • Tianjin Puli Ark Medical Technology Co., Ltd.

    lead OTHER

Principal Investigators

  • Jiayuan Sun · Shanghai Chest Hospital

  • Calvin Ng · Chinese University of Hong Kong, Prince of Wales Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-11-21
Primary Completion
2026-12-30
Completion
2027-03-31
FDA Device
Yes

Countries

  • China
  • Hong Kong

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07301411 on ClinicalTrials.gov